Kerrie Moreau
Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endothelium, Vascular | 21 | 2023 | 923 | 5.160 |
Why?
| Menopause | 12 | 2022 | 270 | 5.110 |
Why?
| Postmenopause | 16 | 2020 | 307 | 3.880 |
Why?
| Vascular Stiffness | 11 | 2023 | 429 | 3.270 |
Why?
| Aging | 17 | 2023 | 1694 | 2.810 |
Why?
| Estrogens | 12 | 2023 | 325 | 2.450 |
Why?
| Estradiol | 7 | 2020 | 477 | 2.230 |
Why?
| Brachial Artery | 13 | 2020 | 183 | 2.120 |
Why?
| Carotid Arteries | 12 | 2021 | 189 | 2.050 |
Why?
| Vasodilation | 12 | 2020 | 462 | 2.010 |
Why?
| Testosterone | 4 | 2022 | 353 | 1.980 |
Why?
| Cardiovascular Diseases | 15 | 2023 | 1859 | 1.940 |
Why?
| Vascular Diseases | 4 | 2022 | 251 | 1.940 |
Why?
| Oxidative Stress | 12 | 2022 | 1204 | 1.770 |
Why?
| Exercise | 14 | 2023 | 1743 | 1.750 |
Why?
| Gonadal Steroid Hormones | 3 | 2019 | 123 | 1.300 |
Why?
| Nitric Oxide Synthase Type III | 4 | 2022 | 198 | 1.190 |
Why?
| Body Composition | 8 | 2022 | 668 | 1.110 |
Why?
| Cardiovascular Physiological Phenomena | 3 | 2021 | 40 | 1.050 |
Why?
| Ascorbic Acid | 5 | 2016 | 116 | 1.050 |
Why?
| Sex Characteristics | 5 | 2023 | 690 | 0.960 |
Why?
| Compliance | 6 | 2018 | 44 | 0.870 |
Why?
| Aged | 33 | 2023 | 20495 | 0.870 |
Why?
| Perimenopause | 3 | 2022 | 60 | 0.870 |
Why?
| Antioxidants | 4 | 2022 | 581 | 0.840 |
Why?
| Baroreflex | 1 | 2022 | 53 | 0.840 |
Why?
| Female | 57 | 2023 | 63629 | 0.780 |
Why?
| Muscle, Skeletal | 4 | 2020 | 1556 | 0.780 |
Why?
| Femoral Artery | 4 | 2006 | 182 | 0.760 |
Why?
| Hyperemia | 1 | 2020 | 43 | 0.750 |
Why?
| Middle Aged | 38 | 2023 | 28563 | 0.750 |
Why?
| Estrogen Replacement Therapy | 5 | 2013 | 118 | 0.750 |
Why?
| Blood Vessels | 2 | 2019 | 193 | 0.740 |
Why?
| Polycystic Ovary Syndrome | 2 | 2019 | 158 | 0.710 |
Why?
| Homocysteine | 2 | 2019 | 138 | 0.700 |
Why?
| Physical Endurance | 5 | 2013 | 234 | 0.700 |
Why?
| Premenopause | 6 | 2020 | 109 | 0.670 |
Why?
| Humans | 70 | 2023 | 122796 | 0.650 |
Why?
| Cysteine | 1 | 2019 | 187 | 0.630 |
Why?
| Muscle Proteins | 1 | 2019 | 218 | 0.610 |
Why?
| Bone Density | 1 | 2021 | 451 | 0.600 |
Why?
| Regional Blood Flow | 4 | 2020 | 427 | 0.590 |
Why?
| Ovary | 1 | 2018 | 209 | 0.590 |
Why?
| Adult | 32 | 2023 | 32385 | 0.590 |
Why?
| Arginine | 1 | 2017 | 254 | 0.560 |
Why?
| Pulmonary Disease, Chronic Obstructive | 6 | 2021 | 1265 | 0.550 |
Why?
| Ventricular Function, Left | 3 | 2023 | 493 | 0.520 |
Why?
| Estrogen Receptor alpha | 2 | 2019 | 126 | 0.480 |
Why?
| Nitric Oxide | 4 | 2023 | 884 | 0.470 |
Why?
| Cross-Sectional Studies | 9 | 2022 | 4734 | 0.460 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 148 | 0.450 |
Why?
| Health | 1 | 2012 | 81 | 0.420 |
Why?
| Male | 34 | 2023 | 59639 | 0.420 |
Why?
| Ultrasonography | 6 | 2018 | 740 | 0.420 |
Why?
| Hysterectomy | 1 | 2012 | 119 | 0.410 |
Why?
| Young Adult | 11 | 2022 | 11094 | 0.400 |
Why?
| Cognitive Dysfunction | 3 | 2021 | 309 | 0.390 |
Why?
| Depression | 1 | 2018 | 1190 | 0.360 |
Why?
| Vasodilator Agents | 1 | 2012 | 339 | 0.360 |
Why?
| Renal Insufficiency, Chronic | 3 | 2023 | 602 | 0.360 |
Why?
| Follicle Stimulating Hormone | 2 | 2021 | 218 | 0.350 |
Why?
| Immunoglobulin G | 1 | 2013 | 804 | 0.340 |
Why?
| Tunica Intima | 2 | 2006 | 79 | 0.340 |
Why?
| Smoking | 4 | 2022 | 1556 | 0.330 |
Why?
| Quality of Life | 2 | 2021 | 2457 | 0.330 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 1181 | 0.320 |
Why?
| Transgender Persons | 2 | 2021 | 134 | 0.320 |
Why?
| Biomarkers | 5 | 2020 | 3662 | 0.290 |
Why?
| Ventricular Dysfunction, Left | 2 | 2023 | 401 | 0.280 |
Why?
| Plethysmography | 2 | 2022 | 125 | 0.270 |
Why?
| Menstrual Cycle | 2 | 2020 | 115 | 0.270 |
Why?
| Vasoconstriction | 1 | 2006 | 216 | 0.260 |
Why?
| Oxygen Consumption | 5 | 2016 | 613 | 0.260 |
Why?
| Absorptiometry, Photon | 3 | 2021 | 230 | 0.240 |
Why?
| Women's Health | 2 | 2019 | 277 | 0.240 |
Why?
| Inflammation | 4 | 2023 | 2598 | 0.230 |
Why?
| Diastole | 3 | 2023 | 147 | 0.230 |
Why?
| Elastin | 1 | 2023 | 78 | 0.230 |
Why?
| Peroxynitrous Acid | 1 | 2022 | 13 | 0.220 |
Why?
| Blood Pressure | 3 | 2022 | 1713 | 0.220 |
Why?
| Adolescent | 13 | 2022 | 18948 | 0.220 |
Why?
| Blood Flow Velocity | 2 | 2022 | 333 | 0.220 |
Why?
| Exercise Therapy | 2 | 2022 | 375 | 0.200 |
Why?
| Ultrasonography, Doppler | 1 | 2022 | 105 | 0.200 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2017 | 294 | 0.200 |
Why?
| Transsexualism | 1 | 2021 | 17 | 0.200 |
Why?
| Sex Factors | 4 | 2022 | 1860 | 0.200 |
Why?
| Progesterone | 1 | 2002 | 243 | 0.200 |
Why?
| Follicular Phase | 1 | 2020 | 42 | 0.190 |
Why?
| Leg | 1 | 2002 | 249 | 0.190 |
Why?
| Cardiology | 1 | 2023 | 338 | 0.190 |
Why?
| Heart Rate | 2 | 2022 | 756 | 0.190 |
Why?
| Carotid Artery Diseases | 1 | 2020 | 61 | 0.180 |
Why?
| Insulin Resistance | 2 | 2020 | 1192 | 0.180 |
Why?
| Cardiomyopathies | 1 | 2023 | 308 | 0.180 |
Why?
| Receptor, Endothelin B | 1 | 2019 | 53 | 0.170 |
Why?
| Taurine | 1 | 2019 | 46 | 0.170 |
Why?
| Cystathionine beta-Synthase | 1 | 2019 | 60 | 0.170 |
Why?
| Body Mass Index | 4 | 2020 | 2144 | 0.170 |
Why?
| Smokers | 1 | 2019 | 169 | 0.160 |
Why?
| Homocystinuria | 1 | 2019 | 63 | 0.160 |
Why?
| Interleukin-6 | 1 | 2022 | 702 | 0.160 |
Why?
| Sports | 1 | 2000 | 197 | 0.160 |
Why?
| Androgens | 1 | 2019 | 169 | 0.160 |
Why?
| Lactic Acid | 1 | 1999 | 283 | 0.150 |
Why?
| Sleep Apnea, Obstructive | 1 | 2021 | 237 | 0.150 |
Why?
| Biomedical Research | 1 | 2023 | 630 | 0.150 |
Why?
| Apyrase | 1 | 2017 | 15 | 0.150 |
Why?
| Oxidation-Reduction | 1 | 2020 | 931 | 0.150 |
Why?
| Metabolism | 1 | 2017 | 40 | 0.150 |
Why?
| Cholecalciferol | 1 | 2017 | 51 | 0.150 |
Why?
| Calcitriol | 1 | 2017 | 55 | 0.150 |
Why?
| Risk Factors | 6 | 2021 | 9381 | 0.150 |
Why?
| Venoms | 1 | 2016 | 33 | 0.140 |
Why?
| Nutritional Status | 1 | 2019 | 306 | 0.140 |
Why?
| Neuropsychological Tests | 2 | 2021 | 1072 | 0.140 |
Why?
| Diabetic Cardiomyopathies | 1 | 2016 | 40 | 0.140 |
Why?
| Pulse Wave Analysis | 3 | 2023 | 216 | 0.140 |
Why?
| Affect | 1 | 2018 | 254 | 0.140 |
Why?
| Attention | 1 | 2019 | 443 | 0.140 |
Why?
| Cognition | 2 | 2021 | 1066 | 0.140 |
Why?
| Mitral Valve | 1 | 2016 | 94 | 0.140 |
Why?
| Peripheral Arterial Disease | 1 | 2022 | 398 | 0.140 |
Why?
| Analysis of Variance | 1 | 2018 | 1329 | 0.130 |
Why?
| Echocardiography | 2 | 2016 | 591 | 0.130 |
Why?
| Diabetic Angiopathies | 1 | 2016 | 270 | 0.120 |
Why?
| Receptors, Estrogen | 1 | 2017 | 388 | 0.120 |
Why?
| Heart Ventricles | 2 | 2016 | 741 | 0.120 |
Why?
| Antigens, CD | 1 | 2017 | 506 | 0.120 |
Why?
| Glomerular Filtration Rate | 1 | 2017 | 697 | 0.120 |
Why?
| Etanercept | 1 | 2013 | 51 | 0.120 |
Why?
| Dietary Supplements | 1 | 2017 | 473 | 0.120 |
Why?
| Psychometrics | 1 | 2017 | 672 | 0.120 |
Why?
| Administration, Cutaneous | 1 | 2013 | 126 | 0.120 |
Why?
| Venous Thromboembolism | 1 | 2017 | 239 | 0.120 |
Why?
| Adaptation, Physiological | 1 | 2017 | 510 | 0.110 |
Why?
| Healthy Volunteers | 1 | 2013 | 209 | 0.110 |
Why?
| Upper Extremity | 2 | 2013 | 85 | 0.110 |
Why?
| Hormone Replacement Therapy | 1 | 2013 | 80 | 0.110 |
Why?
| Ovariectomy | 1 | 2012 | 125 | 0.110 |
Why?
| Receptors, CCR5 | 1 | 2012 | 55 | 0.110 |
Why?
| Cervix Uteri | 1 | 2012 | 48 | 0.100 |
Why?
| Fluorescent Antibody Technique | 2 | 2009 | 420 | 0.100 |
Why?
| Heart | 1 | 2015 | 649 | 0.100 |
Why?
| Diet | 1 | 2019 | 1168 | 0.100 |
Why?
| Administration, Oral | 1 | 2013 | 786 | 0.100 |
Why?
| Time Factors | 3 | 2019 | 6682 | 0.100 |
Why?
| Peptides | 1 | 2016 | 893 | 0.100 |
Why?
| Animals | 4 | 2023 | 34133 | 0.100 |
Why?
| Double-Blind Method | 3 | 2023 | 1711 | 0.100 |
Why?
| Resistance Training | 1 | 2013 | 122 | 0.100 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 302 | 0.100 |
Why?
| Surveys and Questionnaires | 2 | 2021 | 4882 | 0.090 |
Why?
| Kidney | 1 | 2017 | 1355 | 0.090 |
Why?
| Pediatric Obesity | 1 | 2017 | 541 | 0.090 |
Why?
| Gene Expression Regulation | 1 | 2019 | 2491 | 0.090 |
Why?
| Case-Control Studies | 3 | 2020 | 3296 | 0.090 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2017 | 2127 | 0.080 |
Why?
| Walking | 2 | 2015 | 435 | 0.080 |
Why?
| Hypoglycemic Agents | 1 | 2016 | 1055 | 0.080 |
Why?
| Retrospective Studies | 3 | 2022 | 13433 | 0.080 |
Why?
| Aged, 80 and over | 3 | 2012 | 6845 | 0.080 |
Why?
| NADPH Oxidases | 1 | 2007 | 141 | 0.070 |
Why?
| HIV-1 | 1 | 2012 | 783 | 0.070 |
Why?
| Clothing | 1 | 2006 | 25 | 0.070 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2012 | 1003 | 0.070 |
Why?
| Risk Assessment | 3 | 2021 | 3213 | 0.070 |
Why?
| Models, Theoretical | 2 | 2000 | 574 | 0.070 |
Why?
| Waist-Hip Ratio | 1 | 2005 | 31 | 0.070 |
Why?
| Prospective Studies | 3 | 2023 | 6704 | 0.070 |
Why?
| Vascular Resistance | 2 | 2006 | 374 | 0.070 |
Why?
| Disease Susceptibility | 2 | 2021 | 343 | 0.070 |
Why?
| Activities of Daily Living | 2 | 2021 | 361 | 0.060 |
Why?
| DNA Methylation | 1 | 2009 | 511 | 0.060 |
Why?
| Data Collection | 1 | 2008 | 667 | 0.060 |
Why?
| Elasticity | 1 | 2005 | 192 | 0.060 |
Why?
| Exercise Tolerance | 2 | 2016 | 245 | 0.060 |
Why?
| Norepinephrine | 1 | 2005 | 214 | 0.060 |
Why?
| Executive Function | 2 | 2020 | 406 | 0.060 |
Why?
| Inflammation Mediators | 2 | 2017 | 515 | 0.060 |
Why?
| Endothelial Cells | 1 | 2009 | 749 | 0.060 |
Why?
| Cholesterol, LDL | 1 | 2005 | 326 | 0.060 |
Why?
| Bicarbonates | 1 | 2023 | 48 | 0.060 |
Why?
| Proteins | 1 | 2009 | 953 | 0.060 |
Why?
| Sodium Bicarbonate | 1 | 2023 | 51 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2016 | 2221 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2023 | 131 | 0.050 |
Why?
| Overweight | 1 | 2007 | 516 | 0.050 |
Why?
| Cardiac Output | 1 | 2002 | 154 | 0.050 |
Why?
| Prognosis | 2 | 2021 | 3563 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 3114 | 0.050 |
Why?
| Physical Education and Training | 1 | 2002 | 61 | 0.050 |
Why?
| Ankle Brachial Index | 1 | 2022 | 32 | 0.050 |
Why?
| Cardiovascular System | 1 | 2023 | 132 | 0.050 |
Why?
| Cohort Studies | 1 | 2012 | 5294 | 0.050 |
Why?
| Sympathetic Nervous System | 1 | 2002 | 173 | 0.050 |
Why?
| Follow-Up Studies | 3 | 2020 | 4768 | 0.050 |
Why?
| Carotid Artery, Common | 1 | 2021 | 30 | 0.050 |
Why?
| Aorta | 1 | 2023 | 368 | 0.050 |
Why?
| Triglycerides | 1 | 2023 | 527 | 0.050 |
Why?
| Arteries | 2 | 2016 | 256 | 0.050 |
Why?
| Fibrinolytic Agents | 1 | 2022 | 257 | 0.040 |
Why?
| Reference Values | 1 | 2000 | 789 | 0.040 |
Why?
| Lipids | 2 | 2017 | 614 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2019 | 2784 | 0.040 |
Why?
| Respiratory Function Tests | 1 | 2019 | 563 | 0.040 |
Why?
| Stress, Physiological | 1 | 2021 | 433 | 0.040 |
Why?
| Myocardium | 1 | 2023 | 982 | 0.040 |
Why?
| HIV Infections | 1 | 2012 | 2532 | 0.040 |
Why?
| Self-Assessment | 1 | 2017 | 66 | 0.040 |
Why?
| Colorado | 2 | 2017 | 4325 | 0.040 |
Why?
| Carotid Intima-Media Thickness | 1 | 2017 | 68 | 0.040 |
Why?
| Culture | 1 | 2017 | 129 | 0.040 |
Why?
| Energy Metabolism | 1 | 2022 | 783 | 0.040 |
Why?
| Memory Disorders | 1 | 2017 | 170 | 0.040 |
Why?
| Glucose Clamp Technique | 1 | 2017 | 195 | 0.040 |
Why?
| Metabolic Diseases | 1 | 2017 | 104 | 0.030 |
Why?
| Treatment Outcome | 2 | 2022 | 9692 | 0.030 |
Why?
| Adipose Tissue | 1 | 2020 | 616 | 0.030 |
Why?
| Reaction Time | 1 | 2017 | 416 | 0.030 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2016 | 105 | 0.030 |
Why?
| Alternative Splicing | 1 | 2017 | 197 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 1855 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2015 | 105 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1477 | 0.030 |
Why?
| Child | 3 | 2020 | 19561 | 0.030 |
Why?
| HEK293 Cells | 1 | 2017 | 651 | 0.030 |
Why?
| Vitamin D | 1 | 2017 | 363 | 0.030 |
Why?
| Obesity | 1 | 2007 | 2786 | 0.030 |
Why?
| Diabetes Mellitus | 1 | 2022 | 985 | 0.030 |
Why?
| Recovery of Function | 1 | 2017 | 610 | 0.030 |
Why?
| Lost to Follow-Up | 1 | 2013 | 22 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2023 | 5020 | 0.030 |
Why?
| Ventricular Function, Right | 1 | 2015 | 262 | 0.030 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2013 | 49 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2017 | 507 | 0.030 |
Why?
| Stress, Psychological | 1 | 2021 | 1021 | 0.030 |
Why?
| Patient Dropouts | 1 | 2013 | 69 | 0.030 |
Why?
| Hypertension | 1 | 2022 | 1245 | 0.030 |
Why?
| Stroke Volume | 1 | 2015 | 553 | 0.030 |
Why?
| Exercise Test | 1 | 2015 | 588 | 0.030 |
Why?
| ADP-ribosyl Cyclase 1 | 1 | 2012 | 36 | 0.030 |
Why?
| Geriatric Assessment | 1 | 2013 | 187 | 0.030 |
Why?
| Genotype | 1 | 2017 | 1943 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 416 | 0.020 |
Why?
| HLA-DR Antigens | 1 | 2012 | 228 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2015 | 1947 | 0.020 |
Why?
| Muscle Strength | 1 | 2013 | 290 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2013 | 1174 | 0.020 |
Why?
| Xanthine Oxidase | 1 | 2009 | 82 | 0.020 |
Why?
| Transcription Factor RelA | 1 | 2009 | 82 | 0.020 |
Why?
| Veins | 1 | 2009 | 63 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 1021 | 0.020 |
Why?
| Patient Compliance | 1 | 2013 | 561 | 0.020 |
Why?
| Serine | 1 | 2009 | 142 | 0.020 |
Why?
| Infant, Newborn | 1 | 2020 | 5430 | 0.020 |
Why?
| Tyrosine | 1 | 2009 | 267 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1981 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2017 | 2359 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2009 | 418 | 0.020 |
Why?
| Blood Glucose | 1 | 2017 | 1957 | 0.020 |
Why?
| Reference Standards | 1 | 2008 | 177 | 0.020 |
Why?
| Superoxide Dismutase | 1 | 2009 | 345 | 0.020 |
Why?
| Monitoring, Ambulatory | 1 | 2008 | 86 | 0.020 |
Why?
| Insulin | 1 | 2017 | 2180 | 0.020 |
Why?
| Linear Models | 1 | 2009 | 854 | 0.020 |
Why?
| Lung | 1 | 2019 | 3830 | 0.020 |
Why?
| Mice | 1 | 2023 | 15888 | 0.020 |
Why?
| Infant | 1 | 2020 | 8523 | 0.020 |
Why?
| Sodium, Dietary | 1 | 2006 | 44 | 0.020 |
Why?
| Child, Preschool | 1 | 2020 | 9755 | 0.020 |
Why?
| DNA | 1 | 2012 | 1401 | 0.020 |
Why?
| Phosphorylation | 1 | 2009 | 1733 | 0.020 |
Why?
| Body Weight | 1 | 2008 | 958 | 0.010 |
Why?
| Regression Analysis | 1 | 2006 | 1018 | 0.010 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2003 | 112 | 0.010 |
Why?
| United States | 1 | 2019 | 13272 | 0.010 |
Why?
| Pulse | 1 | 1980 | 30 | 0.010 |
Why?
| Ear | 1 | 1980 | 33 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2006 | 2977 | 0.010 |
Why?
| Hemodynamics | 1 | 2003 | 1036 | 0.010 |
Why?
| Transducers | 1 | 1980 | 27 | 0.000 |
Why?
| Systole | 1 | 1980 | 178 | 0.000 |
Why?
| Arrhythmias, Cardiac | 1 | 1980 | 310 | 0.000 |
Why?
|
|
Moreau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|